Skip to main content
 
HOME FOR INVENTORS FOR INDUSTRY FOR ENTREPRENEURS
 
    Innovation Sphere

Researchers

  • Randy Longman
  • Dan Littman
  • Jose Scher
  • Andrew Sczesnak
  • Eric Palmer
  • Steven Abramson
  • Hannah Fehlner-Peach
  • Nicola Segata
  • Carles Ubeda
  • Curtis Huttenhower

Communicate

Details

Project TitlePrevotella copri and Enhanced Susceptibility to Arthritis
Track Code7523
Short Description

The inventors have described methods for the diagnosis and prognosis of Rheumatoid Arthritis (RA).

Abstract

Technology Overview

RA is a chronic inflammatory disease that primarily affects the synovial joints. Roughly 1% of the Caucasian population is afflicted with the disease, which is more common in women than men. Most patients are diagnosed between 30-55 years of age, and the incidence of RA increases with age. Although the exact cause of the disease is unknown, certain genetic and infectious factors have been implicated. Soluble cytokines and chemokines, such as IL-1β and TNFα, are also associated with RA. RA may manifest itself as a mild, self-limiting arthritis to rapidly progressing multi-system inflammation. RA is treated with non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, steroids and analgesics.

The RA test measures rheumatoid factor – the IgM autoantibody reactive with the Fc region epitopes of the IgG molecule. However, these antibodies can be detected in normal healthy individuals, and hence have low disease specificity. New methods for the accurate diagnosis of RA are therefore urgently required.

Animal models have suggested a role for intestinal bacteria in supporting the systemic immune response required for joint inflammation. The inventors performed high throughput 16S and shotgun sequencing of samples from RA patients and controls and identified Prevotella copri (P. copri) as strongly correlated with disease in new onset RA (NORA) patients. The inventors also identified 17 unique P. copri open reading frames that correlated with disease. Colonization of mice showed that P. copri can dominate the intestinal microbiota resulting in an increased sensitivity to colitis and inflammatory arthritis.

Potential Applications

This invention could be used as a diagnostic indicator for RA onset, as a predictive indicator for RA onset in susceptible individuals and as a prognostic indicator for patients already receiving treatment.

 
Tagssequencing, life sciences, inflammation
 
Posted DateAug 3, 2017 10:23 PM

Researcher

Name
Randy Longman
Dan Littman
Jose Scher
Andrew Sczesnak
Eric Palmer
Steven Abramson
Hannah Fehlner-Peach
Nicola Segata
Carles Ubeda
Curtis Huttenhower

Additional Information

Licensing Contact

Brian J. Kelly, Director
bjk44@cornell.edu
646-962-7045

Files

File Name Description
D7523 PcopriRA.docx Tech Brief Download